Home Tools
Log in
Cart

Search Result

Search Results for " canonical "

20

Compounds

Cat No. Product Name Synonyms Targets
T2298 ML204 TRP/TRPV Channel
ML204 is a novel potent antagonist that selectively modulates native TRPC4/C5 ion channels.
T7399 LF3 Wnt/beta-catenin
LF3 is a specific inhibitor of canonical Wnt signaling by disrupting the interaction between β-catenin and TCF4 (IC50 < 2 μM)
T15633 JW74 Wnt/beta-catenin
JW74 antagonizes LiCl-induced activation of the canonical Wnt signaling (IC50: 420 nM).
T4662 SJ000291942 TGF-beta/Smad
SJ000291942 is an activator of the canonical bone morphogenetic proteins (BMP) signaling pathway.
T8820 BML-284 hydrochloride BML-284 HCL,Wnt agonist 1 HCL Wnt/beta-catenin
BML-284 hydrochloride (Wnt agonist 1 HCL) is a potent, selective Wnt canonical signaling activator and tubulin polymerization inhibitor.
T22884 JW 67 Wnt/beta-catenin
JW 67 is an inhibitor of canonical Wnt pathway signaling. JW 67 rapidly reduced active β-catenin with a subsequent downregulation of Wnt target genes, including AXIN2, SP5, and NKD1.
T9263 Cim0216 N-(5-methyl-1,2-oxazol-3-yl)-2-phenyl-2-(1,2,3,4-tetrahydroquinolin-1-yl)acetamide TRP/TRPV Channel
CIM0216 is a synthetic TRPM3 activator whose potency and apparent affinity greatly exceeds that of the canonical TRPM3 agonist.
T16687 Pyr3 TRP/TRPV Channel
Pyr3 is a selective transient receptor potential canonical channel 3 inhibitor. Pyr3 inhibits TRPC3-mediated Ca2+ influx in a dose-dependent manner(IC50 = 700 nM).
T8404 Kasugamycin hydrochloride hydrate Ksg (hydrochloride hydrate) Antibacterial , Antibiotic
Kasugamycin hydrochloride hydrate (Ksg (hydrochloride hydrate))(Ksg) specifically inhibits translation initiation of canonical but not of leaderless messenger RNAs. Ksg inhibition is thought to occur by direct competitio...
TN7036 N-(3-Methoxybenzyl)-(9Z,12Z,15Z)-octadecatrienamide (9Z,12Z,15Z)-N-[(3-Methoxyphenyl)methyl]-9,12,15-octadecatrienamide,Macamide Impurity 14 Wnt/beta-catenin
N-(3-Methoxybenzyl)-(9Z,12Z,15Z)-octadecatrienamide (Macamide Impurity 14) induces osteogenic differentiation and subsequent bone formation of mesenchymal stem cells by activating the canonical Wnt/β-catenin signaling pa...
T12797 RU-SKI 43 RUSKI 43 Hedgehog/Smoothened , Acyltransferase
RU-SKI 43 is a potent and selective hedgehog acyltransferase (Hhat) inhibitor with an IC50 of 850 nM.RU-SKI 43 has anticancer activity and is a potential compound for the treatment of lung adenocarcinomas.RU-SKI 43 reduc...
T3701 MCC950 CP-456773 NOD
CP-456773 (MCC950 (CP-456773) and CRID3) is an effective and specific cytokine release inhibitor and NLRP3 inflammasome inhibitor. CP-456773 inhibits IL-1β secretion and caspase 1 processing. MCC950 blocked canonical and...
T15541 Hyperforin dicyclohexylammonium salt Hyperforin DCHA Others
Hyperforin dicyclohexylammonium salt is a transient receptor canonical 6 channel activator with antidepressant effect. It modulates Ca2+ levels by activating Ca2+-conducting non-selective canonical TRPC6 channels.
T34271 RBPI-3
RBPI-3 is a canonical poly(ADP-ribose) glycohydrolase.
T13213 TRPC6-IN-1 Others
TRPC6-IN-1 is an inhibitor of the Transient Receptor Potential Canonical 6 Channel (TRPC6) (EC50: 4.66 μM).
T72008 E09241
E09241 is a novel OPG/RANKL upregulator, increasing OPG expression without affecting RANKL expression, promoting osteoblast differentiation while inhibiting osteoclast differentiation, regulating OPG expression through c...
T60357 NF-κB-IN-2 JEUD-38
NF-κB-IN-2 inhibits canonical NF-κB signaling induced by TNF-α in PC-3 cells.
T75550 Hyp9
Hyp9, a specific agonist for the transient receptor potential canonical 6 (TRPC6) channel, is utilized in spinal cord injury (SCI) research [1].
T69842 DB2313 HCl
DB2313 is a first-in-class potent small-molecule inhibitor of PU.1. DB2313 disrupts the interaction of PU.1 with target gene promoters and leads to down-regulation of canonical PU.1 transcriptional targets.
T71147 PBS-1086
PBS-1086 is a novel dual inhibitor of the canonical and noncanonical NF-κB pathways, increasing the magnitude and duration of initial EGFR inhibitor response in multiple NSCLC models, decreasing PDHK1 expression, and sup...
1 2
TargetMol